Nuclear post-transcriptional control of gene expression

Journal of Molecular Endocrinology

Volumn 27, Issue 2, 2001, Pages 123-131

  Akker, S A ^a   Smith, P J ^a   Chew, S L ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN; MESSENGER RNA; RNA; RNA BINDING PROTEIN; RNA POLYMERASE II;

ALTERNATIVE RNA SPLICING; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONTROLLED STUDY; GENE ACTIVITY; GENE DISRUPTION; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; RAT; REVIEW; RNA PROCESSING; RNA SPLICING; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ANIMALS; CELL NUCLEUS; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; RNA POLYMERASE II; RNA PRECURSORS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA SPLICING; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 0034791702     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0270123     Document Type: Review

References (115)

1. A handful of intron-containing genes produces the lion's share of yeast mRNA
2. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
3. Last but not least: Regulated poly(A) tail formation
4. Protein diversity from alternative splicing: A challenge for bioinformatics and post-genome biology
5. Poly(A) polymerase phosphorylation is dependent on novel interactions with cyclins
6. Connections between pre-mRNA processing and regulation of the eukaryotic cell cycle
7. A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon
8. In vitro regulation of rat prolactin messenger ribonucleic acid poly(A) tail length: Modulation by bromocriptine
9. C. elegans Sequencing Consortium: 1998 Genome sequence of the nematode C. elegans: A platform for investigating biology
10. Regulation of alternative splicing of protein kinase Cb by insulin
11. Alternative splicing of mRNA as a mode of endocrine regulation
12. An alternatively spliced human IGF-I transcript (IGF-IEc) with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide
13. Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing
14. An exonic splicing silencer in the testes-specific DNA ligase III beta exon
15. Gene number. What if there are only 30 000 human genes?
16. Inhibition of poly(A) polymerase requires p34 cdc2/cyclin B phosphorylation of multiple consensus and non-consensus sites
17. Dexamethasone differentially affects the levels of calcitonin and calcitonin gene-related peptide mRNAs expressed in a human medullary thyroid carcinoma cell line
18. A novel mechanism for regulating activity of a transcription factor that controls the unfolded protein response
19. Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer
20. Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors
21. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer
22. HRS/SRp40-mediated inclusion of the fibronectin EIIIB exon, a possible cause of increased EIIIB expression in proliferating liver
23. Alternative poly(A) site selection in complex transcription units: Means to an end?
24. Pathways for selection of the 5′ splice sites by U1 snRNPs and SF2/ASF
25. Human genomic sequences that inhibit splicing
26. Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase C
27. Pituitary hormone FSH directs the CREM functional switch during spermatogenesis
28. Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides
29. Life with 6000 genes
30. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus rev protein regulate alternative splicing
31. Sorting out the complexity of SR protein functions
32. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors
33. Chronic ethanol exposure and withdrawal influence NMDA receptor subunit and splice variant mRNA expression in the rat cerebral cortex
34. RNA polymerase II is an essential mRNA polyadenylation factor
35. RNA polymerase II and the integration of nuclear events
36. RNA editing
37. The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation
38. Hyperinsulinaemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey
39. Altered insulin receptor messenger ribonucleic acid splicing in liver is associated with deterioration of glucose tolerance in the spontaneously obese and diabetic rhesus monkey: Analysis of a controversy between and human studies
40. Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element
41. Hepatocyte growth factor/scatter factor (HGF/SF) is a regulator of fibronectin splicing in MDCK cells: Comparison between the effects of HGF/SF and TGF-beta1 on fibronectin splicing at the EDA region
42. International Human Genome Sequencing Consortium 2001 Initial sequencing and analysis of the human genome
43. Neuronal cell expression of inserted isoforms of vertebrate nonmuscle myosin heavy chain II-B
44. Sequence of cDNA encoding human insulin-like growth factor I precursor
45. 2-Aminopurine selectively inhibits splicing of tumor necrosis factor alpha mRNA
46. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation
47. Regulated expression and RNA processing of transcripts from the SRp20 splicing factor gene during the cell cycle
48. Gene structure prediction and alternative splicing analysis using genomically aligned ESTs
49. A rapid screening for steroid 21-hydroxylase mutations in patients with congenital adrenal hyperplasia. Mutations in brief no. 247. Online
50. The BARD1-CstF-50 interaction links mRNA 3′ end formation to DNA damage and tumor suppression
51. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator
52. Effects of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells
53. The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites
54. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences
55. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding
56. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation
57. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro
58. Overexpression of growth hormone affects alternatively spliced IGF-I mRNA expression in oMtla-oGH transgenic mice
59. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins
60. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions
61. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes
62. The expression of two splice variants of the Kv3.1 potassium channel gene is regulated by different signaling pathways
63. Mechanisms of tissue-specific alternative RNA processing of the calcitonin/CGRP gene
64. Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: Evidence for differential processing and regulation in liver
65. A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras
66. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription
67. The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors
68. SR proteins and splicing control
69. Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein
70. HnRNP A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways
71. Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity
72. RNA splicing: What has phosphorylation got to do with it?
73. RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo
74. Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo
75. The role of phosphorylation in pre-mRNA splicing
76. Germline mutations in the multiple endocrine neoplasia type 1 gene: Evidence for frequent splicing defects
77. Regulation of pre-mRNA processing by src
78. Differences in the ratio of RNA encoding two isoforms of the insulin receptor between control and NIDDM patients
79. Regulation of human insulin receptor RNA splicing in HepG2 cells: Effects of glucocorticoid and low glucose concentration
80. Regulation of human insulin receptor RNA splicing in vivo
81. Heterogeneity in polyadenylation cleavage sites in mammalian mRNA sequences: Implications for SAGE analysis
82. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer
83. A role for exon sequences and splice-site proximity in splice-site selection
84. Spliceosome assembly
85. Exon definition may facilitate splice site selection in RNAs with multiple exons
86. Two insulin-like growth factor I messenger RNAs are expressed in human liver
87. Polyadenylation and control of neuroendocrine gene expression
88. Selection and characterization of pre-mRNA splicing enhancers: Identification of novel SR protein-specific enhancer sequences
89. Identification and characterisation of three members of the human SR family of pre-mRNA splicing factors
90. Insulin-inducible changes in insulin receptor mRNA splice variants
91. Exonic splicing enhancers contribute to the use of both 3′ and 5′ splice site usage of rat beta-tropomyosin pre-mRNA
92. Growth factor-inducible alternative splicing of nontransmembrane phosphotyrosine phosphatase PTP-1B premessenger RNA
93. A guide to RNA editing
94. Selective regulation of agrin mRNA induction and alternative splicing in PC12 cells by ras-dependent actions of nerve growth factor
95. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
96. Novel exonic elements that modulate splicing of the human fibronectin EDA exon
97. Mechanical devices of the spliceosome: Motors, clocks, springs, and things
98. Hormonal regulation of mRNA stability and RNA-protein interactions in the pituitary
99. Multiple splicing defects in an intronic false exon
100. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer
101. A novel human insulin-like growth factor I messenger RNA is expressed in normal and tumor cells
102. A single-base change at a splice site in a beta O-thalassemic gene causes abnormal RNA splicing
103. The association of nonsense codons with exon skipping
104. T-STAR/etoile: A novel relative of SAM68 that interacts with an RNA-binding protein implicated in spermatogenesis
105. The sequence of the human genome
106. hnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cells
107. SC35 plays a role in T cell development and alternative splicing of CD45
108. Hormonal regulation of alternative splicing
109. Insulin receptor mRNA splicing and altered metabolic control in aged and mildly insulin-deficient rats
110. Cloning and characterization of two novel thyroid hormone receptor beta isoforms
111. Effects of chronic alcohol consumption on the expression of different NR1 splice variants in the brain of AA and ANA lines of rats
112. A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels
113. Control of alternative splicing of potassium channels by stress hormones
114. Change in plasma membrane Ca-ATPase splice-variant expression in response to a rise in intracellular calcium
115. Modification of alternative messenger RNA splicing of fibroblast growth factor receptors in human cardiac allografts during rejection